You are here

Non-Comparative Study To Evaluate Changes In FMD After Quinapril Therapy In Hypertensive Women

Last updated on February 21, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Hodmezovasarhely, Csongrad, Hungary
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Menopause, Hypertension
Sex
Female
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-75 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- pathological baseline FMD (

- women in post-menopause at least for 2 years (post-menopausal defined as having
amenorrhea for Å 2 years)

- mild or moderate hypertension (BP > 140/90 mmHg)

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- uncontrolled severe hypertension (BP > 180/110 mmHg)

NCT00147524
Pfizer
Completed
Non-Comparative Study To Evaluate Changes In FMD After Quinapril Therapy In Hypertensive Women

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now